Michael Biermer
Publications by Year
Research Areas
Hepatitis B Virus Studies, Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis Viruses Studies and Epidemiology, RNA Interference and Gene Delivery
Most-Cited Works
- → Transluminal endoscopic necrosectomy after acute pancreatitis: a multicentre study with long-term follow-up (the GEPARD Study)(2009)481 cited
- → Viscoelasticity-based Staging of Hepatic Fibrosis with Multifrequency MR Elastography(2010)221 cited
- → Tumor Necrosis Factor Alpha Inhibition of Hepatitis B Virus Replication Involves Disruption of Capsid Integrity through Activation of NF-κB(2003)164 cited
- → Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB(2022)100 cited
- → Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy(2010)81 cited
- → Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial(2023)69 cited
- → A case of HBV-induced liver failure in the REEF-2 phase II trial: Implications for finite treatment strategies in HBV ‘cure’(2022)64 cited
- → Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection(2023)54 cited
- → Short-term treatment with RNA interference therapy, JNJ-3989, results in sustained hepatitis B surface antigen supression in patients with chronic hepatitis B receiving nucleos(t)ide analogue treatment(2020)39 cited
- → JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2(2024)39 cited